Welcome To The 4th Microbiome Movement - Drug Development Summit

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

World-Class Speaker Faculty

Alison Lawton

CEO

Kaleido Biosciences

Bernat Olle

CEO

Vedanta Biosciences

Cathryn Nagler

Bunning Food Allergy Professor

University of Chicago

Eric Shaff

CEO

Seres Therapeutics

Esi Lamouse-Smith

Director - Early Development Translational Medicine in Immunology

Janssen Pharmaceuticals

Ken Blount

CSO

Rebiotix

Mike Romanos

CEO

Microbiotica

Ulrich Thienel

Chief Medical Officer

Finch Therapeutics Group

Hear What Our Customers Say

"As a newcomer to the microbiome field, this conference provided an excellent overview.”

Richard Shanksky
Seres  Therapeutics

“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”

Nanae Izumi
Daiichi Sankyo

Proud To Partner With

Expertise Partners:

Industry Partner:

Other Confirmed Partners:

Other Events In The Series